NYAX Q1 2026 Earnings EPS Falls Short of Estimates Despite Strong Stock Reaction Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum CTOR Q1 2026 Earnings Significant EPS Miss Amid PreRevenue Phase ABXL Q1 2026 Earnings Modest EPS Miss Amid Stable Operations Penumbra Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Nexxen International Q3 2025 Earnings Strong EPS Surprise Amplifies Confidence in Profitability BLK Q1 2026 Earnings Strong EPS Beat Driven by Fee Income and Asset Growth GPC Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Edges Higher Incannex Healthcare IXHL Q1 2026 Earnings Deepening Losses as ClinicalStage Biotech Continues PreRevenue Development PTCT Q1 2026 Earnings Significant EPS Beat Highlights Cost Discipline Amid Pipeline Progress SSSSL Q1 2026 Earnings EPS of 518 Surges Past Negative Estimate Net Asset Value May Drive Surprise GAUZ Q2 2025 Earnings Significant EPS Miss Amid Challenging Quarter